Vanderbilt Kennedy Center

Vanderbilt researchers Beth Malow, MD, MS, left, Maria Niarchou, PhD, and Lea Davis, PhD, hope to create a genetic risk profile of insomnia in autism spectrum disorder to better inform treatments.

Study explores genetic risk profiling of insomnia in autism

Vanderbilt researchers are studying how genes affect sleep and circadian disturbances in autism spectrum disorder (ASD) with a goal of creating a genetic risk profile of insomnia in ASD.

New app to help pediatricians recognize autism risk in young children

Researchers fro have been awarded $1 million from the National Institute of Mental Health to evaluate a new mobile app designed to help pediatricians recognize autism risk in young children.

System set to help coordinate autism care

Researchers from the Vanderbilt Kennedy Center Treatment and Research Institute for Autism Spectrum Disorders (TRIAD) are establishing a learning and family navigation system to improve care coordination for children with ASD, particularly those in medically underserved areas.

Treating core Rett syndrome symptoms

A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents.

From left, Deborah Wofford, Janet Shouse and Beth Malow, MD, MS, are among a team of Vanderbilt Kennedy Center researchers seeking to improve access to care for adults with autism.

Kennedy Center program seeks to help community providers treat adults with autism

Researchers at the Vanderbilt Kennedy Center are on a quest to increase health care capacity for adults with autism by bringing quality care into their communities.

Immune ‘pruning’ in schizophrenia

Ariel Deutch and colleagues have discovered that overactive brain immune cells during adolescence may contribute to schizophrenia.

1 2 3 4 5 11